| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.0025 | 1 |